These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2839625)

  • 21. The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.
    Zoccali C; Mallamaci F; Parlongo S
    J Hypertens; 1994 Nov; 12(11):1249-53. PubMed ID: 7868872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypotensive mechanism of potassium supplementation in salt-loaded patients with essential hypertension.
    Tabuchi Y; Ogihara T; Gotoh S; Masuo K; Hashizume K; Kumahara Y
    J Clin Hypertens; 1985 Jun; 1(2):145-52. PubMed ID: 3869819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Salt-sensitive" essential hypertension in men. Is the sodium ion alone important?
    Kurtz TW; Al-Bander HA; Morris RC
    N Engl J Med; 1987 Oct; 317(17):1043-8. PubMed ID: 3309653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine enhances salt sensitivity of body water composition as assessed by impedance among psoriatic patients with normal renal function.
    Coroas AS; de Oliveira JG; Magina S; Santos J; Pestana M; de Almeida MD
    J Ren Nutr; 2004 Oct; 14(4):226-32. PubMed ID: 15483783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary excretion of endogenous digitalis-like natriuretic substances in healthy subjects. Effect of sodium load.
    Asbert M; Jiménez W; La Villa G; Clària J; López C; Ginés P; Gaya J; Castro A; Rivera F; Arroyo V
    Rev Esp Fisiol; 1990 Sep; 46(3):261-7. PubMed ID: 1965341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
    Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
    Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of dietary sodium in hypertension not treated with drugs].
    Krzesinski JM; Du F; Pequeux ML; Rorive G
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1201-4. PubMed ID: 1336357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.
    Delva P; Degan M; Capra C; Fallo F; Mantero F; Menegazzi M; Lechi C; Steele A; Lechi A
    Miner Electrolyte Metab; 1989; 15(5):315-20. PubMed ID: 2554104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ouabain-like and non-ouabain-like factors in plasma of patients with essential hypertension.
    Masugi F; Ogihara T; Hasegawa T; Kumahara Y
    Clin Exp Hypertens A; 1987; 9(7):1233-42. PubMed ID: 3040306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical, experimental, and clinical studies on endogenous ouabain-like substance in hypertension.
    Cloix JF; Crabos M; Devynck MA; Elghozi JL; Henning G; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB
    Adv Nephrol Necker Hosp; 1985; 14():161-71. PubMed ID: 2579533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of circulating sodium-pump inhibitory activity in uraemia and essential hypertension.
    Stokes GS; Willcocks D; Monaghan J; Boutagy J; Marwood JF
    J Hypertens Suppl; 1986 Dec; 4(6):S376-8. PubMed ID: 2441015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of Na+-K+ ATPase activity on blood pressure regulation and sodium metabolism in DOCA-treated rats].
    Shigetomi S; Tosaki H; Ueno S; Kohno H; Mori K; Katoh K; Tanaka K; Haga H; Kin S; Matsunaga A
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1198-207. PubMed ID: 2556303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ouabainlike Na+,K+-ATPase inhibitor in the plasma of normotensive and hypertensive humans and rats.
    de Wardener HE; Millett J; Holland S; MacGregor GA; Alaghband-Zadeh J
    Hypertension; 1987 Nov; 10(5 Pt 2):I52-6. PubMed ID: 2824366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between high sodium diet and hypertension and results of intervention in high sodium diet population].
    Lai FR
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):168-70. PubMed ID: 1395960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma sodium-potassium ATPase inhibition activity in low- and normal-renin hypertension.
    Keane P; Burgess E; Watanabe M; Wong T
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):9-13. PubMed ID: 1848765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ouabainlike compound in hypertension associated with ectopic corticotropin syndrome.
    Goto A; Yamada K; Hazama H; Uehara Y; Atarashi K; Hirata Y; Kimura K; Omata M
    Hypertension; 1996 Sep; 28(3):421-5. PubMed ID: 8794827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress and sodium hypertension in baboons: neuroendocrine and pharmacotherapeutic assessments.
    Turkkan JS; Goldstein DS
    J Hypertens; 1991 Oct; 9(10):969-75. PubMed ID: 1658140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.